Validity of Self-reported Hypertension and Factors Related to Discordance Between Self-reported and Objectively Measured Hypertension: Evidence From a Cohort Study in Iran
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives: Self-reporting can be used to determine the incidence and prevalence of hypertension (HTN). The present study was conducted to determine the validity of self-reported HTN and to identify factors affecting discordance between self-reported and objectively measured HTN in participants in the Ravansar Non-Communicable Diseases (RaNCD) cohort. Methods: The RaNCD cohort included permanent residents of Ravansar, Iran aged 35-65 years. Self-reported data were collected before clinical examinations were conducted by well-trained staff members. The gold standard for HTN was anti-hypertensive medication use and blood pressure measurements. The sensitivity, specificity, positive and negative predictive values, and overall accuracy of self-reporting were calculated. Univariate and multivariate logistic regression were used to examine the discordance between self-reported HTN and the gold standard. Results: Of the 10 065 participants in the RaNCD, 4755 (47.4%) were male. The prevalence of HTN was 16.8% based on self-reporting and 15.7% based on medical history and HTN measurements. Of the participants with HTN, 297 (18.8%) had no knowledge of their disease, and 313 (19.9%) had not properly controlled their HTN despite receiving treatment. The sensitivity, specificity, and kappa for self-reported HTN were 75.5%, 96.4%, and 73.4%, respectively. False positives became more likely with age, body mass index (BMI), low socioeconomic status, and female sex, whereas false negatives became more likely with age, BMI, high socioeconomic status, smoking, and urban residency. Conclusions: The sensitivity and specificity of self-reported HTN were acceptable, suggesting that this method can be used for public health initiatives in the absence of countrywide HTN control and detection programs.
Abstract
Objectives: Self-reporting can be used to determine the incidence and prevalence of hypertension (HTN). The present study was conducted to determine the validity of self-reported HTN and to identify factors affecting discordance between self-reported and objectively measured HTN in participants in the Ravansar Non-Communicable Diseases (RaNCD) cohort. Methods: The RaNCD cohort included permanent residents of Ravansar, Iran aged 35-65 years. Self-reported data were collected before clinical examinations were conducted by well-trained staff members. The gold standard for HTN was anti-hypertensive medication use and blood pressure measurements. The sensitivity, specificity, positive and negative predictive values, and overall accuracy of self-reporting were calculated. Univariate and multivariate logistic regression were used to examine the discordance between self-reported HTN and the gold standard. Results: Of the 10 065 participants in the RaNCD, 4755 (47.4%) were male. The prevalence of HTN was 16.8% based on self-reporting and 15.7% based on medical history and HTN measurements. Of the participants with HTN, 297 (18.8%) had no knowledge of their disease, and 313 (19.9%) had not properly controlled their HTN despite receiving treatment. The sensitivity, specificity, and kappa for self-reported HTN were 75.5%, 96.4%, and 73.4%, respectively. False positives became more likely with age, body mass index (BMI), low socioeconomic status, and female sex, whereas false negatives became more likely with age, BMI, high socioeconomic status, smoking, and urban residency. Conclusions: The sensitivity and specificity of self-reported HTN were acceptable, suggesting that this method can be used for public health initiatives in the absence of countrywide HTN control and detection programs.
참고문헌 (38)
- NCD Risk Factor Collaboration(NCD-RisC), "Worldwide trends in blood pressure from 1975 to 2015 : a pooled analysis of 1479 population-based measurement studies with 19·1 million participants", Lancet, 389(10064), pp.37~55 (2017)
- Zhong Y, "Secular changes in cardiovascular risk factors in Swedish 50-year-old men over a 50-year period : the study of men born in 1913, 1923, 1933, 1943, 1953 and 1963", Eur J Prev Cardiol, 24(6), pp.612~620 (2017)
- Lawes CM, "Blood pressure and the global burden of disease 2000. Part II: estimates of attributable burden", J Hypertens, 24(3), pp.423~430 (2006)
- Chobanian AV, "The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure : the JNC 7 report", JAMA, 289(19), pp.2560~2572 (2003)
- Kearney PM, "Global burden of hypertension : analysis of worldwide data", Lancet, 365(9455), pp.217~223 (2005)
- Centers for Disease Control and Prevention (CDC), "Vital signs: prevalence, treatment, and control of hypertension--United States, 1999-2002 and 2005-2008", MMWR Morb Mortal Wkly Rep, 60(4), pp.103~108 (2011)
- Centers for Disease Control and Prevention (CDC), "Vital signs : prevalence, treatment, and control of high levels of low-density lipoprotein cholesterol—United States, 1999-2002 and 2005-200", MMWR Morb Mortal Wkly Rep, 60(4), pp.109~114 (2011)
- Wolf-Maier K, "Hypertension treatment and control in five European countries, Canada, and the United States", Hypertension, 43(1), pp.10~17 (2004)
- Fagard RH, "Survey on treatment of hypertension and implementation of World Health Organization", International Society of Hypertension risk stratification in primary care in Belgium, 2002, pp.20(7), 1297~1302
- Poustchi H, "Prospective epidemiological research studies in Iran(the PERSIAN Cohort Study) : rationale, objectives, and design", Am J Epidemiol, 187(4), pp.647~655 (2018)
- Eghtesad S, "The PERSIAN cohort : providing the evidence needed for healthcare reform", Arch Iran Med, 20(11), pp.691~695 (2017)
- Pasdar Y, "Cohort profile: Ravansar Non-Communicable Disease cohort study: the first cohort study in a Kurdish population", Int J Epidemiol (2019)[DOI]
- Whelton PK, "2017 ACC", AHA, ABC, pp.ACPM, AGS[DOI]
- "DHS comparative reports No. 6: the DHS wealth index" (2004)[URL]
- Ong KL, "Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004", Hypertension, 49(1), pp.69~75 (2007)
- Sharma AM, "High prevalence and poor control of hypertension in primary care : cross-sectional study", J Hypertens, 22(3), pp.479~486 (2004)
- Anchala R, "Hypertension in India : a systematic review and meta-analysis of prevalence, awareness, and control of hypertension", J Hypertens, 32(6), pp.1170~1177 (2014)
- Cooper RS, "An international comparative study of blood pressure in populations of European vs. African descent", BMC Med, 3, pp.2~ (2005)
- Lu J, "Prevalence, awareness, treatment, and control of hypertension in China : data from 1·7 million adults in a population-based screening study(China PEACE Million Persons Project)", Lancet, 390(10112), pp.2549~2558 (2017)
- Esteghamati A, "Prevalence, awareness, treatment, and risk factors associated with hypertension in the Iranian population : the national survey of risk factors for noncommunicable diseases of Iran", Am J Hypertens, 21(6), pp.620~626 (2008)
- Tenkorang EY, "Validity of self‐report data in hypertension research: findings from the Study on Global Ageing and Adult Health", J Clin Hypertens(Greenwich), 17(12), pp.977~984 (2015)
- 전희란, "Accuracy of Self-reported Hypertension, Diabetes, and Hypercholesterolemia: Analysis of a Representative Sample of Korean Older Adults", Osong Public Health and Research Perspectives, 7(2), pp.108~115 (2016), 질병관리청
- Thawornchaisit P, "Validity of self-reported hypertension : findings from the Thai Cohort Study compared to physician telephone interview", Glob J Health Sci, 6(2), pp.1~11 (2013)
- Teteh DK, "Validity of self-reported high blood pressure among black and white seventh-day Adventists", Int J Health Sci Res, 7(7), pp.212~220 (2017)
- Alonso A, "Validation of self reported diagnosis of hypertension in a cohort of university graduates in Spain", BMC Public Health, 5, pp.94~ (2005)
- Bigdeli MA, "Factors associated with self-care behavior in patients with type ii diabetes", J Mazandaran Univ Med Sci, 25(125), pp.61~72 (2015)[DOI]
- Bergmann MM, "Validity of self-reported cancers in a prospective cohort study in comparison with data from state cancer registries", Am J Epidemiol, 147(6), pp.556~562 (1998)
- Engstad T, "Validity of self-reported stroke : the Tromso Study", Stroke, 31(7), pp.1602~1607 (2000)
- Goldman N, "Evaluating the quality of self-reports of hypertension and diabetes", J Clin Epidemiol, 56(2), pp.148~154 (2003)
- Farzadfar F, "Effectiveness of diabetes and hypertension management by rural primary health-care workers(Behvarz workers)in Iran : a nationally representative observational study", Lancet, 379(9810), pp.47~54 (2012)
- Ahn S, "Hypertension awareness and associated factors among older Chinese adults", Front Public Health, 1, pp.67~ (2013)
- Giles WH, "The validity of self-reported hypertension and correlates of hypertension awareness among blacks and whites within the stroke belt", Am J Prev Med, 11(3), pp.163~169 (1995)
- Friedman-Gerlicz C, "Misclassification rates in hypertension diagnosis due to measurement errors", Soc Ind Appl Math, 2(2), pp.46~57 (2009)
- Elliott WJ, "Drug interactions and drugs that affect blood pressure", J Clin Hypertens(Greenwich), 8(10), pp.731~737 (2006)
- Egan BM, "Initial monotherapy and combination therapy and hypertension control the first year", Hypertension, 59(6), pp.1124~1131 (2012)
- Li W, "Hypertension prevalence, awareness, treatment, and control in 115 rural and urban communities involving 47 000 people from China", J Hypertens, 34(1), pp.39~46 (2016)
- Valizadeh G, "Investigating the consistancy rate of hypertension treatment through guide line JNC-7, in patients who were referred to health centers and health houses of Fasa University of Medical Sciences 2012", J Fasa Univ Med Sci, 4(1), pp.74~80 (2014)
- Woollard J, "Effects of general practice-based nurse-counselling on ambulatory blood pressure and antihypertensive drug prescription in patients at increased risk of cardiovascular disease", J Hum Hypertens, 17(10), pp.689~ (2003)